INS and diabetes mellitus: These results indicate that diabetes substantially reduces AMPK activity in the liver, but the administration of kaempferol-3-rhamnoside and insulin substantially enhances the p-AMPK/AMPK ratio, thereby activating AMPK function in hepatic tissues.